According to Cognitive Market Research, the global Collagen Based Biomaterials market size was USD 5854.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 4.00% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 2341.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.2% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1756.26 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1346.47 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.0% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 292.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 117.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.
The medical and healthcare sector stands as the dominant end use. This dominance is driven by the extensive use of collagen in various medical applications such as wound healing, tissue repair, and surgical implants.
